PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32412768-3	2020	Herein, we have performed a comprehensive screening of site-specific N-glycopeptides in serum haptoglobin (Hp), a reporter molecule for aberrant glycosylation in HCC, to characterize glycopeptide markers for NASH-related HCCs.	n-glycopeptides	69-84	haptoglobin	Homo sapiens	94-105	
30370771-0	2019	Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.	n-glycopeptides	64-79	haptoglobin	Homo sapiens	89-100	
30370771-2	2019	Herein, we developed a workflow that involved advanced methodologies, the EThcD-MS/MS fragmentation method and data interpretation software, for differential analysis of the microheterogeneity of site-specific intact N-glycopeptides of serum haptoglobin between early hepatocellular carcinoma (HCC) and liver cirrhosis.	n-glycopeptides	217-232	haptoglobin	Homo sapiens	242-253	
34779613-6	2021	Finally, our results illustrated the aberrant sialylation of haptoglobin (Hp) in hepatocellular carcinoma (HCC), where the ratios of alpha2,3 to alpha2,6 sialylation of seven N-glycopeptides were found to be significantly altered (p < 0.01) in HCC individuals (n = 27) compared with healthy controls (n = 27).	n-glycopeptides	175-190	haptoglobin	Homo sapiens	61-72	
22223312-3	2012	The experimental data showed that the microcolumn could efficiently and reproducibly isolate N-glycopeptides from enzymatic mixtures of ovalbumin, fetuin, haptoglobin and human plasma.	n-glycopeptides	93-108	haptoglobin	Homo sapiens	155-166	
34436504-0	2021	PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma.	n-glycopeptides	41-56	haptoglobin	Homo sapiens	82-93